Source: Investing.com ↗

Tenax Therapeutics CEO Christopher Giordano acquires $20,087 in shares

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.01%

BTC/USDT

$86,194.01

+0.84%

ETH/USDT

$2,743.31

+0.45%

ZEC/USDT

$1,624.26

+7.04%

XRP/USDT

$1.61

+5.98%